Intercept to Present at Upcoming Investor Conferences in June
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Intercept Pharmaceuticals (ICPT) PT Lowered to $106 at Citi
May 30, 2019 7:30 AM EDTCiti analyst Joel Beatty lowered the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $106.00 (from $140.00) while maintaining a Neutral rating. Beatty believes obeticholic acid is very likely to receive approval for NASH in ~3Q20, and see the drug becoming the standard of care for... More
